0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Eye Drops for Glaucoma Market Research Report 2024
Published Date: April 2024
|
Report Code: QYRE-Auto-17K15136
Home | Market Reports | Health| Vision Care
Global Eye Drops for Glaucoma Market Insights Forecast to 2029
BUY CHAPTERS

Global Eye Drops for Glaucoma Market Research Report 2024

Code: QYRE-Auto-17K15136
Report
April 2024
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Eye Drops for Glaucoma Market

The global Eye Drops for Glaucoma market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Eye Drops for Glaucoma is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Eye Drops for Glaucoma is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Eye Drops for Glaucoma include Thea Pharmaceuticals Ltd, FDC International Ltd, Martindale Pharma, Zentiva, Upjohn UK Limited, Beacon Pharmaceuticals, Novartis Pharmaceuticals UK Ltd, Mylan and Accord Healthcare Limited, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Eye Drops for Glaucoma, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Eye Drops for Glaucoma.

Report Scope

The Eye Drops for Glaucoma market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Eye Drops for Glaucoma market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Eye Drops for Glaucoma manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Eye Drops for Glaucoma Market Report

Report Metric Details
Report Name Eye Drops for Glaucoma Market
Segment by Type
  • Bimatoprost
  • Latanoprost
  • Tafluprost
  • Travoprost
Segment by Application
  • Hospital
  • Ophthalmic Clinic
  • Pharmacy
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Thea Pharmaceuticals Ltd, FDC International Ltd, Martindale Pharma, Zentiva, Upjohn UK Limited, Beacon Pharmaceuticals, Novartis Pharmaceuticals UK Ltd, Mylan, Accord Healthcare Limited, Sandoz Limited, Thornton & Ross Ltd, Aspire Pharma Ltd, AbbVie Ltd
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Eye Drops for Glaucoma manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Eye Drops for Glaucoma in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Eye Drops for Glaucoma Market report?

Ans: The main players in the Eye Drops for Glaucoma Market are Thea Pharmaceuticals Ltd, FDC International Ltd, Martindale Pharma, Zentiva, Upjohn UK Limited, Beacon Pharmaceuticals, Novartis Pharmaceuticals UK Ltd, Mylan, Accord Healthcare Limited, Sandoz Limited, Thornton & Ross Ltd, Aspire Pharma Ltd, AbbVie Ltd

What are the Application segmentation covered in the Eye Drops for Glaucoma Market report?

Ans: The Applications covered in the Eye Drops for Glaucoma Market report are Hospital, Ophthalmic Clinic, Pharmacy, Others

What are the Type segmentation covered in the Eye Drops for Glaucoma Market report?

Ans: The Types covered in the Eye Drops for Glaucoma Market report are Bimatoprost, Latanoprost, Tafluprost, Travoprost

1 Eye Drops for Glaucoma Market Overview
1.1 Product Overview and Scope of Eye Drops for Glaucoma
1.2 Eye Drops for Glaucoma Segment by Type
1.2.1 Global Eye Drops for Glaucoma Market Value Comparison by Type (2024-2030)
1.2.2 Bimatoprost
1.2.3 Latanoprost
1.2.4 Tafluprost
1.2.5 Travoprost
1.3 Eye Drops for Glaucoma Segment by Application
1.3.1 Global Eye Drops for Glaucoma Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Ophthalmic Clinic
1.3.4 Pharmacy
1.3.5 Others
1.4 Global Eye Drops for Glaucoma Market Size Estimates and Forecasts
1.4.1 Global Eye Drops for Glaucoma Revenue 2019-2030
1.4.2 Global Eye Drops for Glaucoma Sales 2019-2030
1.4.3 Global Eye Drops for Glaucoma Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Eye Drops for Glaucoma Market Competition by Manufacturers
2.1 Global Eye Drops for Glaucoma Sales Market Share by Manufacturers (2019-2024)
2.2 Global Eye Drops for Glaucoma Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Eye Drops for Glaucoma Average Price by Manufacturers (2019-2024)
2.4 Global Eye Drops for Glaucoma Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Eye Drops for Glaucoma, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Eye Drops for Glaucoma, Product Type & Application
2.7 Eye Drops for Glaucoma Market Competitive Situation and Trends
2.7.1 Eye Drops for Glaucoma Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Eye Drops for Glaucoma Players Market Share by Revenue
2.7.3 Global Eye Drops for Glaucoma Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Eye Drops for Glaucoma Retrospective Market Scenario by Region
3.1 Global Eye Drops for Glaucoma Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Eye Drops for Glaucoma Global Eye Drops for Glaucoma Sales by Region: 2019-2030
3.2.1 Global Eye Drops for Glaucoma Sales by Region: 2019-2024
3.2.2 Global Eye Drops for Glaucoma Sales by Region: 2025-2030
3.3 Global Eye Drops for Glaucoma Global Eye Drops for Glaucoma Revenue by Region: 2019-2030
3.3.1 Global Eye Drops for Glaucoma Revenue by Region: 2019-2024
3.3.2 Global Eye Drops for Glaucoma Revenue by Region: 2025-2030
3.4 North America Eye Drops for Glaucoma Market Facts & Figures by Country
3.4.1 North America Eye Drops for Glaucoma Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Eye Drops for Glaucoma Sales by Country (2019-2030)
3.4.3 North America Eye Drops for Glaucoma Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Eye Drops for Glaucoma Market Facts & Figures by Country
3.5.1 Europe Eye Drops for Glaucoma Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Eye Drops for Glaucoma Sales by Country (2019-2030)
3.5.3 Europe Eye Drops for Glaucoma Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Eye Drops for Glaucoma Market Facts & Figures by Country
3.6.1 Asia Pacific Eye Drops for Glaucoma Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Eye Drops for Glaucoma Sales by Country (2019-2030)
3.6.3 Asia Pacific Eye Drops for Glaucoma Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Eye Drops for Glaucoma Market Facts & Figures by Country
3.7.1 Latin America Eye Drops for Glaucoma Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Eye Drops for Glaucoma Sales by Country (2019-2030)
3.7.3 Latin America Eye Drops for Glaucoma Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Eye Drops for Glaucoma Market Facts & Figures by Country
3.8.1 Middle East and Africa Eye Drops for Glaucoma Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Eye Drops for Glaucoma Sales by Country (2019-2030)
3.8.3 Middle East and Africa Eye Drops for Glaucoma Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Eye Drops for Glaucoma Sales by Type (2019-2030)
4.1.1 Global Eye Drops for Glaucoma Sales by Type (2019-2024)
4.1.2 Global Eye Drops for Glaucoma Sales by Type (2025-2030)
4.1.3 Global Eye Drops for Glaucoma Sales Market Share by Type (2019-2030)
4.2 Global Eye Drops for Glaucoma Revenue by Type (2019-2030)
4.2.1 Global Eye Drops for Glaucoma Revenue by Type (2019-2024)
4.2.2 Global Eye Drops for Glaucoma Revenue by Type (2025-2030)
4.2.3 Global Eye Drops for Glaucoma Revenue Market Share by Type (2019-2030)
4.3 Global Eye Drops for Glaucoma Price by Type (2019-2030)
5 Segment by Application
5.1 Global Eye Drops for Glaucoma Sales by Application (2019-2030)
5.1.1 Global Eye Drops for Glaucoma Sales by Application (2019-2024)
5.1.2 Global Eye Drops for Glaucoma Sales by Application (2025-2030)
5.1.3 Global Eye Drops for Glaucoma Sales Market Share by Application (2019-2030)
5.2 Global Eye Drops for Glaucoma Revenue by Application (2019-2030)
5.2.1 Global Eye Drops for Glaucoma Revenue by Application (2019-2024)
5.2.2 Global Eye Drops for Glaucoma Revenue by Application (2025-2030)
5.2.3 Global Eye Drops for Glaucoma Revenue Market Share by Application (2019-2030)
5.3 Global Eye Drops for Glaucoma Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Thea Pharmaceuticals Ltd
6.1.1 Thea Pharmaceuticals Ltd Corporation Information
6.1.2 Thea Pharmaceuticals Ltd Description and Business Overview
6.1.3 Thea Pharmaceuticals Ltd Eye Drops for Glaucoma Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Thea Pharmaceuticals Ltd Eye Drops for Glaucoma Product Portfolio
6.1.5 Thea Pharmaceuticals Ltd Recent Developments/Updates
6.2 FDC International Ltd
6.2.1 FDC International Ltd Corporation Information
6.2.2 FDC International Ltd Description and Business Overview
6.2.3 FDC International Ltd Eye Drops for Glaucoma Sales, Revenue and Gross Margin (2019-2024)
6.2.4 FDC International Ltd Eye Drops for Glaucoma Product Portfolio
6.2.5 FDC International Ltd Recent Developments/Updates
6.3 Martindale Pharma
6.3.1 Martindale Pharma Corporation Information
6.3.2 Martindale Pharma Description and Business Overview
6.3.3 Martindale Pharma Eye Drops for Glaucoma Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Martindale Pharma Eye Drops for Glaucoma Product Portfolio
6.3.5 Martindale Pharma Recent Developments/Updates
6.4 Zentiva
6.4.1 Zentiva Corporation Information
6.4.2 Zentiva Description and Business Overview
6.4.3 Zentiva Eye Drops for Glaucoma Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Zentiva Eye Drops for Glaucoma Product Portfolio
6.4.5 Zentiva Recent Developments/Updates
6.5 Upjohn UK Limited
6.5.1 Upjohn UK Limited Corporation Information
6.5.2 Upjohn UK Limited Description and Business Overview
6.5.3 Upjohn UK Limited Eye Drops for Glaucoma Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Upjohn UK Limited Eye Drops for Glaucoma Product Portfolio
6.5.5 Upjohn UK Limited Recent Developments/Updates
6.6 Beacon Pharmaceuticals
6.6.1 Beacon Pharmaceuticals Corporation Information
6.6.2 Beacon Pharmaceuticals Description and Business Overview
6.6.3 Beacon Pharmaceuticals Eye Drops for Glaucoma Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Beacon Pharmaceuticals Eye Drops for Glaucoma Product Portfolio
6.6.5 Beacon Pharmaceuticals Recent Developments/Updates
6.7 Novartis Pharmaceuticals UK Ltd
6.6.1 Novartis Pharmaceuticals UK Ltd Corporation Information
6.6.2 Novartis Pharmaceuticals UK Ltd Description and Business Overview
6.6.3 Novartis Pharmaceuticals UK Ltd Eye Drops for Glaucoma Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis Pharmaceuticals UK Ltd Eye Drops for Glaucoma Product Portfolio
6.7.5 Novartis Pharmaceuticals UK Ltd Recent Developments/Updates
6.8 Mylan
6.8.1 Mylan Corporation Information
6.8.2 Mylan Description and Business Overview
6.8.3 Mylan Eye Drops for Glaucoma Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Mylan Eye Drops for Glaucoma Product Portfolio
6.8.5 Mylan Recent Developments/Updates
6.9 Accord Healthcare Limited
6.9.1 Accord Healthcare Limited Corporation Information
6.9.2 Accord Healthcare Limited Description and Business Overview
6.9.3 Accord Healthcare Limited Eye Drops for Glaucoma Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Accord Healthcare Limited Eye Drops for Glaucoma Product Portfolio
6.9.5 Accord Healthcare Limited Recent Developments/Updates
6.10 Sandoz Limited
6.10.1 Sandoz Limited Corporation Information
6.10.2 Sandoz Limited Description and Business Overview
6.10.3 Sandoz Limited Eye Drops for Glaucoma Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Sandoz Limited Eye Drops for Glaucoma Product Portfolio
6.10.5 Sandoz Limited Recent Developments/Updates
6.11 Thornton & Ross Ltd
6.11.1 Thornton & Ross Ltd Corporation Information
6.11.2 Thornton & Ross Ltd Eye Drops for Glaucoma Description and Business Overview
6.11.3 Thornton & Ross Ltd Eye Drops for Glaucoma Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Thornton & Ross Ltd Eye Drops for Glaucoma Product Portfolio
6.11.5 Thornton & Ross Ltd Recent Developments/Updates
6.12 Aspire Pharma Ltd
6.12.1 Aspire Pharma Ltd Corporation Information
6.12.2 Aspire Pharma Ltd Eye Drops for Glaucoma Description and Business Overview
6.12.3 Aspire Pharma Ltd Eye Drops for Glaucoma Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Aspire Pharma Ltd Eye Drops for Glaucoma Product Portfolio
6.12.5 Aspire Pharma Ltd Recent Developments/Updates
6.13 AbbVie Ltd
6.13.1 AbbVie Ltd Corporation Information
6.13.2 AbbVie Ltd Eye Drops for Glaucoma Description and Business Overview
6.13.3 AbbVie Ltd Eye Drops for Glaucoma Sales, Revenue and Gross Margin (2019-2024)
6.13.4 AbbVie Ltd Eye Drops for Glaucoma Product Portfolio
6.13.5 AbbVie Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Eye Drops for Glaucoma Industry Chain Analysis
7.2 Eye Drops for Glaucoma Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Eye Drops for Glaucoma Production Mode & Process
7.4 Eye Drops for Glaucoma Sales and Marketing
7.4.1 Eye Drops for Glaucoma Sales Channels
7.4.2 Eye Drops for Glaucoma Distributors
7.5 Eye Drops for Glaucoma Customers
8 Eye Drops for Glaucoma Market Dynamics
8.1 Eye Drops for Glaucoma Industry Trends
8.2 Eye Drops for Glaucoma Market Drivers
8.3 Eye Drops for Glaucoma Market Challenges
8.4 Eye Drops for Glaucoma Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Eye Drops for Glaucoma Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Eye Drops for Glaucoma Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Eye Drops for Glaucoma Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Eye Drops for Glaucoma Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Eye Drops for Glaucoma Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Eye Drops for Glaucoma Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Eye Drops for Glaucoma Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Eye Drops for Glaucoma Average Price (US$/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Eye Drops for Glaucoma, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Eye Drops for Glaucoma, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Eye Drops for Glaucoma, Product Type & Application
    Table 12. Global Key Manufacturers of Eye Drops for Glaucoma, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Eye Drops for Glaucoma by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Eye Drops for Glaucoma as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Eye Drops for Glaucoma Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Eye Drops for Glaucoma Sales by Region (2019-2024) & (K Units)
    Table 18. Global Eye Drops for Glaucoma Sales Market Share by Region (2019-2024)
    Table 19. Global Eye Drops for Glaucoma Sales by Region (2025-2030) & (K Units)
    Table 20. Global Eye Drops for Glaucoma Sales Market Share by Region (2025-2030)
    Table 21. Global Eye Drops for Glaucoma Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Eye Drops for Glaucoma Revenue Market Share by Region (2019-2024)
    Table 23. Global Eye Drops for Glaucoma Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Eye Drops for Glaucoma Revenue Market Share by Region (2025-2030)
    Table 25. North America Eye Drops for Glaucoma Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Eye Drops for Glaucoma Sales by Country (2019-2024) & (K Units)
    Table 27. North America Eye Drops for Glaucoma Sales by Country (2025-2030) & (K Units)
    Table 28. North America Eye Drops for Glaucoma Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Eye Drops for Glaucoma Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Eye Drops for Glaucoma Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Eye Drops for Glaucoma Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Eye Drops for Glaucoma Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Eye Drops for Glaucoma Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Eye Drops for Glaucoma Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Eye Drops for Glaucoma Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Eye Drops for Glaucoma Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Eye Drops for Glaucoma Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Eye Drops for Glaucoma Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Eye Drops for Glaucoma Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Eye Drops for Glaucoma Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Eye Drops for Glaucoma Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Eye Drops for Glaucoma Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Eye Drops for Glaucoma Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Eye Drops for Glaucoma Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Eye Drops for Glaucoma Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Eye Drops for Glaucoma Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Eye Drops for Glaucoma Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Eye Drops for Glaucoma Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Eye Drops for Glaucoma Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Eye Drops for Glaucoma Sales (K Units) by Type (2019-2024)
    Table 51. Global Eye Drops for Glaucoma Sales (K Units) by Type (2025-2030)
    Table 52. Global Eye Drops for Glaucoma Sales Market Share by Type (2019-2024)
    Table 53. Global Eye Drops for Glaucoma Sales Market Share by Type (2025-2030)
    Table 54. Global Eye Drops for Glaucoma Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Eye Drops for Glaucoma Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Eye Drops for Glaucoma Revenue Market Share by Type (2019-2024)
    Table 57. Global Eye Drops for Glaucoma Revenue Market Share by Type (2025-2030)
    Table 58. Global Eye Drops for Glaucoma Price (US$/Unit) by Type (2019-2024)
    Table 59. Global Eye Drops for Glaucoma Price (US$/Unit) by Type (2025-2030)
    Table 60. Global Eye Drops for Glaucoma Sales (K Units) by Application (2019-2024)
    Table 61. Global Eye Drops for Glaucoma Sales (K Units) by Application (2025-2030)
    Table 62. Global Eye Drops for Glaucoma Sales Market Share by Application (2019-2024)
    Table 63. Global Eye Drops for Glaucoma Sales Market Share by Application (2025-2030)
    Table 64. Global Eye Drops for Glaucoma Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Eye Drops for Glaucoma Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Eye Drops for Glaucoma Revenue Market Share by Application (2019-2024)
    Table 67. Global Eye Drops for Glaucoma Revenue Market Share by Application (2025-2030)
    Table 68. Global Eye Drops for Glaucoma Price (US$/Unit) by Application (2019-2024)
    Table 69. Global Eye Drops for Glaucoma Price (US$/Unit) by Application (2025-2030)
    Table 70. Thea Pharmaceuticals Ltd Corporation Information
    Table 71. Thea Pharmaceuticals Ltd Description and Business Overview
    Table 72. Thea Pharmaceuticals Ltd Eye Drops for Glaucoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 73. Thea Pharmaceuticals Ltd Eye Drops for Glaucoma Product
    Table 74. Thea Pharmaceuticals Ltd Recent Developments/Updates
    Table 75. FDC International Ltd Corporation Information
    Table 76. FDC International Ltd Description and Business Overview
    Table 77. FDC International Ltd Eye Drops for Glaucoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 78. FDC International Ltd Eye Drops for Glaucoma Product
    Table 79. FDC International Ltd Recent Developments/Updates
    Table 80. Martindale Pharma Corporation Information
    Table 81. Martindale Pharma Description and Business Overview
    Table 82. Martindale Pharma Eye Drops for Glaucoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 83. Martindale Pharma Eye Drops for Glaucoma Product
    Table 84. Martindale Pharma Recent Developments/Updates
    Table 85. Zentiva Corporation Information
    Table 86. Zentiva Description and Business Overview
    Table 87. Zentiva Eye Drops for Glaucoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 88. Zentiva Eye Drops for Glaucoma Product
    Table 89. Zentiva Recent Developments/Updates
    Table 90. Upjohn UK Limited Corporation Information
    Table 91. Upjohn UK Limited Description and Business Overview
    Table 92. Upjohn UK Limited Eye Drops for Glaucoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 93. Upjohn UK Limited Eye Drops for Glaucoma Product
    Table 94. Upjohn UK Limited Recent Developments/Updates
    Table 95. Beacon Pharmaceuticals Corporation Information
    Table 96. Beacon Pharmaceuticals Description and Business Overview
    Table 97. Beacon Pharmaceuticals Eye Drops for Glaucoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 98. Beacon Pharmaceuticals Eye Drops for Glaucoma Product
    Table 99. Beacon Pharmaceuticals Recent Developments/Updates
    Table 100. Novartis Pharmaceuticals UK Ltd Corporation Information
    Table 101. Novartis Pharmaceuticals UK Ltd Description and Business Overview
    Table 102. Novartis Pharmaceuticals UK Ltd Eye Drops for Glaucoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 103. Novartis Pharmaceuticals UK Ltd Eye Drops for Glaucoma Product
    Table 104. Novartis Pharmaceuticals UK Ltd Recent Developments/Updates
    Table 105. Mylan Corporation Information
    Table 106. Mylan Description and Business Overview
    Table 107. Mylan Eye Drops for Glaucoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 108. Mylan Eye Drops for Glaucoma Product
    Table 109. Mylan Recent Developments/Updates
    Table 110. Accord Healthcare Limited Corporation Information
    Table 111. Accord Healthcare Limited Description and Business Overview
    Table 112. Accord Healthcare Limited Eye Drops for Glaucoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 113. Accord Healthcare Limited Eye Drops for Glaucoma Product
    Table 114. Accord Healthcare Limited Recent Developments/Updates
    Table 115. Sandoz Limited Corporation Information
    Table 116. Sandoz Limited Description and Business Overview
    Table 117. Sandoz Limited Eye Drops for Glaucoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 118. Sandoz Limited Eye Drops for Glaucoma Product
    Table 119. Sandoz Limited Recent Developments/Updates
    Table 120. Thornton & Ross Ltd Corporation Information
    Table 121. Thornton & Ross Ltd Description and Business Overview
    Table 122. Thornton & Ross Ltd Eye Drops for Glaucoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 123. Thornton & Ross Ltd Eye Drops for Glaucoma Product
    Table 124. Thornton & Ross Ltd Recent Developments/Updates
    Table 125. Aspire Pharma Ltd Corporation Information
    Table 126. Aspire Pharma Ltd Description and Business Overview
    Table 127. Aspire Pharma Ltd Eye Drops for Glaucoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 128. Aspire Pharma Ltd Eye Drops for Glaucoma Product
    Table 129. Aspire Pharma Ltd Recent Developments/Updates
    Table 130. AbbVie Ltd Corporation Information
    Table 131. AbbVie Ltd Description and Business Overview
    Table 132. AbbVie Ltd Eye Drops for Glaucoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 133. AbbVie Ltd Eye Drops for Glaucoma Product
    Table 134. AbbVie Ltd Recent Developments/Updates
    Table 135. Key Raw Materials Lists
    Table 136. Raw Materials Key Suppliers Lists
    Table 137. Eye Drops for Glaucoma Distributors List
    Table 138. Eye Drops for Glaucoma Customers List
    Table 139. Eye Drops for Glaucoma Market Trends
    Table 140. Eye Drops for Glaucoma Market Drivers
    Table 141. Eye Drops for Glaucoma Market Challenges
    Table 142. Eye Drops for Glaucoma Market Restraints
    Table 143. Research Programs/Design for This Report
    Table 144. Key Data Information from Secondary Sources
    Table 145. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Eye Drops for Glaucoma
    Figure 2. Global Eye Drops for Glaucoma Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Eye Drops for Glaucoma Market Share by Type in 2023 & 2030
    Figure 4. Bimatoprost Product Picture
    Figure 5. Latanoprost Product Picture
    Figure 6. Tafluprost Product Picture
    Figure 7. Travoprost Product Picture
    Figure 8. Global Eye Drops for Glaucoma Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 9. Global Eye Drops for Glaucoma Market Share by Application in 2023 & 2030
    Figure 10. Hospital
    Figure 11. Ophthalmic Clinic
    Figure 12. Pharmacy
    Figure 13. Others
    Figure 14. Global Eye Drops for Glaucoma Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Eye Drops for Glaucoma Market Size (2019-2030) & (US$ Million)
    Figure 16. Global Eye Drops for Glaucoma Sales (2019-2030) & (K Units)
    Figure 17. Global Eye Drops for Glaucoma Average Price (US$/Unit) & (2019-2030)
    Figure 18. Eye Drops for Glaucoma Report Years Considered
    Figure 19. Eye Drops for Glaucoma Sales Share by Manufacturers in 2023
    Figure 20. Global Eye Drops for Glaucoma Revenue Share by Manufacturers in 2023
    Figure 21. The Global 5 and 10 Largest Eye Drops for Glaucoma Players: Market Share by Revenue in 2023
    Figure 22. Eye Drops for Glaucoma Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 23. Global Eye Drops for Glaucoma Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 24. North America Eye Drops for Glaucoma Sales Market Share by Country (2019-2030)
    Figure 25. North America Eye Drops for Glaucoma Revenue Market Share by Country (2019-2030)
    Figure 26. United States Eye Drops for Glaucoma Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 27. Canada Eye Drops for Glaucoma Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. Europe Eye Drops for Glaucoma Sales Market Share by Country (2019-2030)
    Figure 29. Europe Eye Drops for Glaucoma Revenue Market Share by Country (2019-2030)
    Figure 30. Germany Eye Drops for Glaucoma Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. France Eye Drops for Glaucoma Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. U.K. Eye Drops for Glaucoma Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. Italy Eye Drops for Glaucoma Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Russia Eye Drops for Glaucoma Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. Asia Pacific Eye Drops for Glaucoma Sales Market Share by Region (2019-2030)
    Figure 36. Asia Pacific Eye Drops for Glaucoma Revenue Market Share by Region (2019-2030)
    Figure 37. China Eye Drops for Glaucoma Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. Japan Eye Drops for Glaucoma Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. South Korea Eye Drops for Glaucoma Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. India Eye Drops for Glaucoma Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Australia Eye Drops for Glaucoma Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. China Taiwan Eye Drops for Glaucoma Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Indonesia Eye Drops for Glaucoma Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Thailand Eye Drops for Glaucoma Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Malaysia Eye Drops for Glaucoma Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Latin America Eye Drops for Glaucoma Sales Market Share by Country (2019-2030)
    Figure 47. Latin America Eye Drops for Glaucoma Revenue Market Share by Country (2019-2030)
    Figure 48. Mexico Eye Drops for Glaucoma Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Brazil Eye Drops for Glaucoma Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Argentina Eye Drops for Glaucoma Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. Middle East & Africa Eye Drops for Glaucoma Sales Market Share by Country (2019-2030)
    Figure 52. Middle East & Africa Eye Drops for Glaucoma Revenue Market Share by Country (2019-2030)
    Figure 53. Turkey Eye Drops for Glaucoma Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. Saudi Arabia Eye Drops for Glaucoma Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 55. UAE Eye Drops for Glaucoma Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 56. Global Sales Market Share of Eye Drops for Glaucoma by Type (2019-2030)
    Figure 57. Global Revenue Market Share of Eye Drops for Glaucoma by Type (2019-2030)
    Figure 58. Global Eye Drops for Glaucoma Price (US$/Unit) by Type (2019-2030)
    Figure 59. Global Sales Market Share of Eye Drops for Glaucoma by Application (2019-2030)
    Figure 60. Global Revenue Market Share of Eye Drops for Glaucoma by Application (2019-2030)
    Figure 61. Global Eye Drops for Glaucoma Price (US$/Unit) by Application (2019-2030)
    Figure 62. Eye Drops for Glaucoma Value Chain
    Figure 63. Eye Drops for Glaucoma Production Process
    Figure 64. Channels of Distribution (Direct Vs Distribution)
    Figure 65. Distributors Profiles
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

RELATED REPORTS

Global High Acuity Care Service Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5D18285
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global mHealth (Mobile Health) Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-18B6151
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Resin Lenses Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-21S7871
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mobile Medical Imaging Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16Q6154
Thu Sep 11 00:00:00 UTC 2025

Add to Cart